Variation in the Cd3ζ (Cd247) gene correlates with altered T cell activation and is associated with autoimmune diabetes

Journal of Immunology

Volumn 184, Issue 10, 2010, Pages 5537-5544

  Lundholm, Marie ^a   Mayans, Sofia ^a,b   Motta, Vinicius ^a,c   Löfgren Burström, Anna ^a   Danska, Jayne ^c   Holmberg, Dan ^a,b  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; T LYMPHOCYTE RECEPTOR; CD3 ANTIGEN, ZETA CHAIN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; GROWTH INHIBITOR; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BAGG ALBINO MOUSE; C3H MOUSE; C57BL 6 MOUSE; CONTROLLED STUDY; DBA 2 MOUSE; DIABETES MELLITUS; FEMALE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PRIORITY JOURNAL; STRAIN DIFFERENCE; T LYMPHOCYTE ACTIVATION; ALLELE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; CONGENIC STRAIN; DBA MOUSE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; SPECIES DIFFERENCE; T LYMPHOCYTE SUBPOPULATION;

ALLELES; ANIMALS; ANTIGENS, CD; ANTIGENS, CD3; CELLS, CULTURED; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GROWTH INHIBITORS; INFLAMMATION; LYMPHOCYTE ACTIVATION; MICE; MICE, CONGENIC; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED NOD; SPECIES SPECIFICITY; T-LYMPHOCYTE SUBSETS;

EID: 77954708525     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0904012     Document Type: Article

References (51)

1. Castaño, L., and G. S. Eisenbarth. 1990. Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu. Rev. Immunol. 8: 647-679.
2. Vyse, T. J., and J. A. Todd. 1996. Genetic analysis of autoimmune disease. Cell 85: 311-318.
3. Delovitch, T. L., and B. Singh. 1997. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7: 727-738.
4. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29: 1-13.
5. Ridgway, W. M., L. B. Peterson, J. A. Todd, D. B. Rainbow, B. Healy, O. S. Burren, and L. S. Wicker. 2008. Gene-gene interactions in the NOD mouse model of type 1 diabetes. Adv. Immunol. 100: 151-175.
6. Wicker, L. S., J. A. Todd, and L. B. Peterson. 1995. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13: 179-200.
7. Hill, N. J., P. A. Lyons, N. Armitage, J. A. Todd, L. S. Wicker, and L. B. Peterson. 2000. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes 49: 1744-1747.
8. Ueda, H., J. M. Howson, L. Esposito, J. Heward, H. Snook, G. Chamberlain, D. B. Rainbow, K. M. Hunter, A. N. Smith, G. Di Genova, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511.
9. Wicker, L. S., G. Chamberlain, K. Hunter, D. Rainbow, S. Howlett, P. Tiffen, J. Clark, A. Gonzalez-Munoz, A. M. Cumiskey, R. L. Rosa, et al. 2004. Fine mapping, gene content, comparative sequencing, and expression analyses support Ctla4 and Nramp1 as candidates for Idd5.1 and Idd5.2 in the nonobese diabetic mouse. J. Immunol. 173: 164-173.
10. Colucci, F., M. L. Bergman, C. Penha-Gonçalves, C. M. Cilio, and D. Holmberg. 1997. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proc. Natl. Acad. Sci. USA 94: 8670-8674.
11. Lundholm, M., V. Motta, A. Löfgren-Burström, N. Duarte, M. L. Bergman, S. Mayans, and D. Holmberg. 2006. Defective induction of CTLA-4 in the NOD mouse is controlled by the NOD allele of Idd3/IL-2 and a novel locus (Ctex) telomeric on chromosome 1. Diabetes 55: 538-544. (Pubitemid 43343287)
12. Samelson, L. E., M. D. Patel, A. M. Weissman, J. B. Harford, and R. D. Klausner. 1986. Antigen activation of murine T cells induces tyrosine phosphorylation of a polypeptide associated with the T cell antigen receptor. Cell 46: 1083-1090.
13. Baniyash, M., P. Garcia-Morales, E. Luong, L. E. Samelson, and R. D. Klausner. 1988. The T cell antigen receptor zeta chain is tyrosine phosphorylated upon activation. J. Biol. Chem. 263: 18225-18230.
14. D'Oro, U., I. Munitic, G. Chacko, T. Karpova, J. McNally, and J. D. Ashwell. 2002. Regulation of constitutive TCR internalization by the zeta-chain. J. Immunol. 169: 6269-6278.
15. Irving, B. A., and A. Weiss. 1991. The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways. Cell 64: 891-901.
16. Zipris, D., A. H. Lazarus, A. R. Crow, M. Hadzija, and T. L. Delovitch. 1991. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice. Evidence for thymic T cell anergy that correlates with the onset of insulitis. J. Immunol. 146: 3763-3771.
17. Rapoport, M. J., A. H. Lazarus, A. Jaramillo, E. Speck, and T. L. Delovitch. 1993. Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation. J. Exp. Med. 177: 1221-1226.
18. Zhang, J., K. V. Salojin, and T. L. Delovitch. 2001. CD28 co-stimulation restores T cell responsiveness in NOD mice by overcoming deficiencies in Rac-1/p38 mitogen-activated protein kinase signaling and IL-2 and IL-4 gene transcription. Int. Immunol. 13: 377-384.
19. Nambiar, M. P., J. P. Mitchell, R. P. Ceruti, M. A. Malloy, and G. C. Tsokos. 2003. Prevalence of T cell receptor zeta chain deficiency in systemic lupus erythematosus. Lupus 12: 46-51. (Pubitemid 36172662)
20. Pang, M., Y. Setoyama, K. Tsuzaka, K. Yoshimoto, K. Amano, T. Abe, and T. Takeuchi. 2002. Defective expression and tyrosine phosphorylation of the T cell receptor zeta chain in peripheral blood T cells from systemic lupus erythematosus patients. Clin. Exp. Immunol. 129: 160-168.
21. Berg, L., J. Rönnelid, L. Klareskog, and A. Bucht. 2000. Down-regulation of the T cell receptor CD3 zeta chain in rheumatoid arthritis (RA) and its influence on T cell responsiveness. Clin. Exp. Immunol. 120: 174-182.
22. Romagnoli, P., D. Strahan, M. Pelosi, A. Cantagrel, and J. P. van Meerwijk. 2001. A potential role for protein tyrosine kinase p56(lck) in rheumatoid arthritis synovial fluid T lymphocyte hyporesponsiveness. Int. Immunol. 13: 305-312.
23. Baniyash, M. 2004. TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Nat. Rev. Immunol. 4: 675-687.
24. Cope, A. P. 2002. Studies of T-cell activation in chronic inflammation. Arthritis Res. 4(Suppl. 3): S197-S211.
25. Hayes, S. M., L. Li, and P. E. Love. 2005. TCR signal strength influences alphabeta/gammadelta lineage fate. Immunity 22: 583-593.
26. Holst, J., H. Wang, K. D. Eder, C. J. Workman, K. L. Boyd, Z. Baquet, H. Singh, K. Forbes, A. Chruscinski, R. Smeyne, et al. 2008. Scalable signaling mediated by T cell antigen receptor-CD3 ITAMs ensures effective negative selection and prevents autoimmunity. Nat. Immunol. 9: 658-666.
27. Pfaffl, M. W., G.W. Horgan, and L. Dempfle. 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30: e36.
28. Friedline, R. H., D. S. Brown, H. Nguyen, H. Kornfeld, J. Lee, Y. Zhang, M. Appleby, S. D. Der, J. Kang, and C. A. Chambers. 2009. CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance. J. Exp. Med. 206: 421-434.
29. Takahashi, T., T. Tagami, S. Yamazaki, T. Uede, J. Shimizu, N. Sakaguchi, T. W. Mak, and S. Sakaguchi. 2000. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyteassociated antigen 4. J. Exp. Med. 192: 303-310.
30. Wing, K., Y. Onishi, P. Prieto-Martin, T. Yamaguchi, M. Miyara, Z. Fehervari, T. Nomura, and S. Sakaguchi. 2008. CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.
31. Greve, B., L. Vijayakrishnan, A. Kubal, R. A. Sobel, L. B. Peterson, L. S. Wicker, and V. K. Kuchroo. 2004. The diabetes susceptibility locus Idd5.1 on mouse chromosome 1 regulates ICOS expression and modulates murine experimental autoimmune encephalomyelitis. J. Immunol. 173: 157-163.
32. Truneh, A., F. Albert, P. Golstein, and A. M. Schmitt-Verhulst. 1985. Early steps of lymphocyte activation bypassed by synergy between calcium ionophores and phorbol ester. Nature 313: 318-320. (Pubitemid 15151988)
33. Ohno, H., T. Aoe, S. Taki, D. Kitamura, Y. Ishida, K. Rajewsky, and T. Saito. 1993. Developmental and functional impairment of T cells in mice lacking CD3 zeta chains. EMBO J. 12: 4357-4366.
34. -/- mutant mice and identification of a novel T cell population in the intestine. EMBO J. 12: 4863-4875.
35. Maurice, M. M., A. C. Lankester, A. C. Bezemer, M. F. Geertsma, P. P. Tak, F. C. Breedveld, R. A. van Lier, and C. L. Verweij. 1997. Defective TCRmediated signaling in synovial T cells in rheumatoid arthritis. J. Immunol. 159: 2973-2978.
36. Tsokos, G. C., H. K. Wong, E. J. Enyedy, and M. P. Nambiar. 2000. Immune cell signaling in lupus. Curr. Opin. Rheumatol. 12: 355-363.
37. Gorman, C. L., A. I. Russell, Z. Zhang, D. Cunninghame Graham, A. P. Cope, and T. J. Vyse. 2008. Polymorphisms in the CD3Z gene influence TCRzeta expression in systemic lupus erythematosus patients and healthy controls. J. Immunol. 180: 1060-1070.
38. Ciszak, L., E. Pawlak, A. Kosmaczewska, S. Potoczek, and I. Frydecka. 2007. Alterations in the expression of signal-transducing CD3 zeta chain in T cells from patients with chronic inflammatory/autoimmune diseases. Arch. Immunol. Ther. Exp. (Warsz.) 55: 373-386.
39. Gill, B. M., A. Jaramillo, L. Ma, K. B. Laupland, and T. L. Delovitch. 1995. Genetic linkage of thymic T-cell proliferative unresponsiveness to mouse chromosome 11 in NOD mice. A possible role for chemokine genes. Diabetes 44: 614-619.
40. Grattan, M., Q. S. Mi, C. Meagher, and T. L. Delovitch. 2002. Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: identification of two potential candidate subloci. Diabetes 51: 215-223. (Pubitemid 34518001)
41. Foulds, K. E., L. A. Zenewicz, D. J. Shedlock, J. Jiang, A. E. Troy, and H. Shen. 2002. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168: 1528-1532.
42. Ravichandran, K. S., and S. J. Burakoff. 1994. Evidence for differential intracellular signaling via CD4 and CD8 molecules. J. Exp. Med. 179: 727-732.
43. Love, P. E., E. W. Shores, M. D. Johnson, M. L. Tremblay, E. J. Lee, A. Grinberg, S. P. Huang, A. Singer, and H. Westphal. 1993. T cell development in mice that lack the zeta chain of the T cell antigen receptor complex. Science 261: 918-921.
44. Malissen, M., A. Gillet, B. Rocha, J. Trucy, E. Vivier, C. Boyer, F. Köntgen, N. Brun, G. Mazza, E. Spanopoulou, et al. 1993. T cell development in mice lacking the CD3-zeta/eta gene. EMBO J. 12: 4347-4355.
45. Yamazaki, T., H. Arase, S. Ono, H. Ohno, H. Watanabe, and T. Saito. 1997. A shift from negative to positive selection of autoreactive T cells by the reduced level of TCR signal in TCR-transgenic CD3 zeta-deficient mice. J. Immunol. 158: 1634-1640. (Pubitemid 127469517)
46. She, J., M. C. Ruzek, P. Velupillai, I. de Aos, B. Wang, D. A. Harn, J. Sancho, C. A. Biron, and C. Terhorst. 1999. Generation of antigen-specific cytotoxic T lymphocytes and regulation of cytokine production takes place in the absence of CD3zeta. Int. Immunol. 11: 845-857.
47. Wicker, L. S., J. Clark, H. I. Fraser, V. E. Garner, A. Gonzalez-Munoz, B. Healy, S. Howlett, K. Hunter, D. Rainbow, R. L. Rosa, et al. 2005. Type 1 diabetes genes and pathways shared by humans and NOD mice. J. Autoimmun. 25 (Suppl.): 29-33. (Pubitemid 41728041)
48. Siggs, O. M., L. A. Miosge, A. L. Yates, E. M. Kucharska, D. Sheahan, T. Brdicka, A. Weiss, A. Liston, and C. C. Goodnow. 2007. Opposing functions of the T cell receptor kinase ZAP-70 in immunity and tolerance differentially titrate in response to nucleotide substitutions. Immunity 27: 912-926.
49. Yamanouchi, J., D. Rainbow, P. Serra, S. Howlett, K. Hunter, V. E. Garner, A. Gonzalez-Munoz, J. Clark, R. Veijola, R. Cubbon, et al. 2007. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat. Genet. 39: 329-337.
50. Dendrou, C. A., V. Plagnol, E. Fung, J. H. Yang, K. Downes, J. D. Cooper, S. Nutland, G. Coleman, M. Himsworth, M. Hardy, et al. 2009. Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat. Genet. 41: 1011-1015.
51. Hakonarson, H., H. Q. Qu, J. P. Bradfield, L. Marchand, C. E. Kim, J. T. Glessner, R. Grabs, T. Casalunovo, S. P. Taback, E. C. Frackelton, et al. 2008. A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association study. Diabetes 57: 1143-1146.